APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blastomycosis Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Blastomycosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17397130032 January 2026188 pages

Choose your research edition.

Industry ResearchBlastomycosis Treatment Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Blastomycosis Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Blastomycosis Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blastomycosis Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Blastomycosis Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Blastomycosis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Blastomycosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blastomycosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blastomycosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Blastomycosis Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Blastomycosis Treatment include Emcure Pharmaceuticals, Hindustan Antibiotics Limited, Sun Pharmaceutical Industries Ltd., Viatris, Merck & Co, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Blastomycosis Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blastomycosis Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blastomycosis Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Blastomycosis Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Blastomycosis Treatment Segment by Company

Emcure Pharmaceuticals

Hindustan Antibiotics Limited

Sun Pharmaceutical Industries Ltd.

Viatris

Merck & Co

Novartis

Sanofi

Blastomycosis Treatment Segment by Type

Itraconazole

Amphotericin B

Others

Blastomycosis Treatment Segment by Application

Hospital

Retail Pharmacy

Other

Blastomycosis Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blastomycosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blastomycosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blastomycosis Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Blastomycosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blastomycosis Treatment industry.

Chapter 3: Detailed analysis of Blastomycosis Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blastomycosis Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blastomycosis Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Itraconazole Table 3. Key Players of Amphotericin B Table 4. Key Players of Others Table 4. Global Blastomycosis Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Blastomycosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Blastomycosis Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Blastomycosis Treatment Market Share by Region (2021-2026) Table 11. Global Blastomycosis Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Blastomycosis Treatment Market Share by Region (2027-2032) Table 13. Blastomycosis Treatment Industry Trends Table 14. Blastomycosis Treatment Industry Drivers Table 15. Blastomycosis Treatment Industry Opportunities and Challenges Table 16. Blastomycosis Treatment Industry Restraints Table 17. Global Blastomycosis Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Blastomycosis Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Blastomycosis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Blastomycosis Treatment Key Company Head Office and Area Served Table 21. Global Blastomycosis Treatment Company, Product Type & Application Table 22. Global Blastomycosis Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Blastomycosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Blastomycosis Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Blastomycosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Blastomycosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Blastomycosis Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Blastomycosis Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Blastomycosis Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Blastomycosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Blastomycosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Blastomycosis Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Blastomycosis Treatment Revenue Market Share by Application (2027-2032) Table 35. Emcure Pharmaceuticals Company Information Table 36. Emcure Pharmaceuticals Business Overview Table 37. Emcure Pharmaceuticals Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Emcure Pharmaceuticals Blastomycosis Treatment Product Portfolio Table 39. Emcure Pharmaceuticals Recent Development Table 40. Hindustan Antibiotics Limited Company Information Table 41. Hindustan Antibiotics Limited Business Overview Table 42. Hindustan Antibiotics Limited Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Hindustan Antibiotics Limited Blastomycosis Treatment Product Portfolio Table 44. Hindustan Antibiotics Limited Recent Development Table 45. Sun Pharmaceutical Industries Ltd. Company Information Table 46. Sun Pharmaceutical Industries Ltd. Business Overview Table 47. Sun Pharmaceutical Industries Ltd. Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Sun Pharmaceutical Industries Ltd. Blastomycosis Treatment Product Portfolio Table 49. Sun Pharmaceutical Industries Ltd. Recent Development Table 50. Viatris Company Information Table 51. Viatris Business Overview Table 52. Viatris Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Viatris Blastomycosis Treatment Product Portfolio Table 54. Viatris Recent Development Table 55. Merck & Co Company Information Table 56. Merck & Co Business Overview Table 57. Merck & Co Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Merck & Co Blastomycosis Treatment Product Portfolio Table 59. Merck & Co Recent Development Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novartis Blastomycosis Treatment Product Portfolio Table 64. Novartis Recent Development Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sanofi Blastomycosis Treatment Product Portfolio Table 69. Sanofi Recent Development Table 70. North America Blastomycosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Blastomycosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Blastomycosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Blastomycosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Blastomycosis Treatment Market Size by Country (2021-2026) Table 76. North America Blastomycosis Treatment Market Size by Country (2027-2032) Table 77. Europe Blastomycosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Blastomycosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Blastomycosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Blastomycosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Blastomycosis Treatment Market Size by Country (2021-2026) Table 83. Europe Blastomycosis Treatment Market Size by Country (2027-2032) Table 84. China Blastomycosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 85. China Blastomycosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 86. China Blastomycosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 87. China Blastomycosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Blastomycosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Blastomycosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Blastomycosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Blastomycosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Blastomycosis Treatment Market Size by Country (2021-2026) Table 94. Asia Blastomycosis Treatment Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Blastomycosis Treatment Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Blastomycosis Treatment Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Blastomycosis Treatment Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Blastomycosis Treatment Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Blastomycosis Treatment Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Blastomycosis Treatment Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Blastomycosis Treatment Product Image Figure 2. Global Blastomycosis Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Blastomycosis Treatment Market Share by Type: 2025 VS 2032 Figure 4. Itraconazole Image Figure 5. Amphotericin B Image Figure 6. Others Image Figure 7. Global Blastomycosis Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Blastomycosis Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Retail Pharmacy Image Figure 11. Other Image Figure 12. Global Blastomycosis Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Blastomycosis Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Blastomycosis Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Blastomycosis Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Blastomycosis Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Blastomycosis Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Blastomycosis Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Blastomycosis Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Blastomycosis Treatment Market Share by Type (2021-2032) Figure 25. North America Blastomycosis Treatment Market Share by Application (2021-2032) Figure 26. North America Blastomycosis Treatment Market Share by Country (2021-2032) Figure 27. United States Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Blastomycosis Treatment Market Share by Type (2021-2032) Figure 32. Europe Blastomycosis Treatment Market Share by Application (2021-2032) Figure 33. Europe Blastomycosis Treatment Market Share by Country (2021-2032) Figure 34. Germany Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Blastomycosis Treatment Market Share by Type (2021-2032) Figure 42. China Blastomycosis Treatment Market Share by Application (2021-2032) Figure 43. Asia Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Blastomycosis Treatment Market Share by Type (2021-2032) Figure 45. Asia Blastomycosis Treatment Market Share by Application (2021-2032) Figure 46. Asia Blastomycosis Treatment Market Share by Country (2021-2032) Figure 47. Japan Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Blastomycosis Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Blastomycosis Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Blastomycosis Treatment Market Share by Country (2021-2032) Figure 57. Brazil Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Blastomycosis Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Itraconazole
  • Amphotericin B
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Emcure Pharmaceuticals
  • Hindustan Antibiotics Limited
  • Sun Pharmaceutical Industries Ltd.
  • Viatris
  • Merck & Co
  • Novartis
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Blastomycosis Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Itraconazole
  5. 1.2.3 Amphotericin B
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Blastomycosis Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Retail Pharmacy
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Blastomycosis Treatment Growth Trends by Region
  14. 1.5.1 Global Blastomycosis Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Blastomycosis Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Blastomycosis Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Blastomycosis Treatment Market Dynamics
  1. 2.1 Blastomycosis Treatment Industry Trends
  2. 2.2 Blastomycosis Treatment Industry Drivers
  3. 2.3 Blastomycosis Treatment Industry Opportunities and Challenges
  4. 2.4 Blastomycosis Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Blastomycosis Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Blastomycosis Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Blastomycosis Treatment Key Company Head office and Area Served
  4. 3.4 Global Blastomycosis Treatment Company, Product Type & Application
  5. 3.5 Global Blastomycosis Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Blastomycosis Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Blastomycosis Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Blastomycosis Treatment Tier 1, Tier 2, and Tier 3
4 Blastomycosis Treatment Market by Type
  1. 4.1 Global Blastomycosis Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Blastomycosis Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Blastomycosis Treatment Market Size Share by Type (2021-2032)
5 Blastomycosis Treatment Market by Application
  1. 5.1 Global Blastomycosis Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Blastomycosis Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Blastomycosis Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Emcure Pharmaceuticals
  2. 6.1.1 Emcure Pharmaceuticals Company Information
  3. 6.1.2 Emcure Pharmaceuticals Business Overview
  4. 6.1.3 Emcure Pharmaceuticals Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Emcure Pharmaceuticals Blastomycosis Treatment Product Portfolio
  6. 6.1.5 Emcure Pharmaceuticals Recent Developments
  7. 6.2 Hindustan Antibiotics Limited
  8. 6.2.1 Hindustan Antibiotics Limited Company Information
  9. 6.2.2 Hindustan Antibiotics Limited Business Overview
  10. 6.2.3 Hindustan Antibiotics Limited Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Hindustan Antibiotics Limited Blastomycosis Treatment Product Portfolio
  12. 6.2.5 Hindustan Antibiotics Limited Recent Developments
  13. 6.3 Sun Pharmaceutical Industries Ltd.
  14. 6.3.1 Sun Pharmaceutical Industries Ltd. Company Information
  15. 6.3.2 Sun Pharmaceutical Industries Ltd. Business Overview
  16. 6.3.3 Sun Pharmaceutical Industries Ltd. Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Industries Ltd. Blastomycosis Treatment Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  19. 6.4 Viatris
  20. 6.4.1 Viatris Company Information
  21. 6.4.2 Viatris Business Overview
  22. 6.4.3 Viatris Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Viatris Blastomycosis Treatment Product Portfolio
  24. 6.4.5 Viatris Recent Developments
  25. 6.5 Merck & Co
  26. 6.5.1 Merck & Co Company Information
  27. 6.5.2 Merck & Co Business Overview
  28. 6.5.3 Merck & Co Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck & Co Blastomycosis Treatment Product Portfolio
  30. 6.5.5 Merck & Co Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Blastomycosis Treatment Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Blastomycosis Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sanofi Blastomycosis Treatment Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Blastomycosis Treatment Market Size (2021-2032)
  2. 7.2 North America Blastomycosis Treatment Market Size by Type
  3. 7.2.1 North America Blastomycosis Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Blastomycosis Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Blastomycosis Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Blastomycosis Treatment Market Size by Application
  7. 7.3.1 North America Blastomycosis Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Blastomycosis Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Blastomycosis Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Blastomycosis Treatment Market Size by Country
  11. 7.4.1 North America Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Blastomycosis Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Blastomycosis Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Blastomycosis Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Blastomycosis Treatment Market Size (2021-2032)
  2. 8.2 Europe Blastomycosis Treatment Market Size by Type
  3. 8.2.1 Europe Blastomycosis Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Blastomycosis Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Blastomycosis Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Blastomycosis Treatment Market Size by Application
  7. 8.3.1 Europe Blastomycosis Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Blastomycosis Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Blastomycosis Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Blastomycosis Treatment Market Size by Country
  11. 8.4.1 Europe Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Blastomycosis Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Blastomycosis Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Blastomycosis Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Blastomycosis Treatment Market Size (2021-2032)
  2. 9.2 China Blastomycosis Treatment Market Size by Type
  3. 9.2.1 China Blastomycosis Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Blastomycosis Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Blastomycosis Treatment Market Share by Type (2021-2032)
  6. 9.3 China Blastomycosis Treatment Market Size by Application
  7. 9.3.1 China Blastomycosis Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Blastomycosis Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Blastomycosis Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Blastomycosis Treatment Market Size (2021-2032)
  2. 10.2 Asia Blastomycosis Treatment Market Size by Type
  3. 10.2.1 Asia Blastomycosis Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Blastomycosis Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Blastomycosis Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Blastomycosis Treatment Market Size by Application
  7. 10.3.1 Asia Blastomycosis Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Blastomycosis Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Blastomycosis Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Blastomycosis Treatment Market Size by Country
  11. 10.4.1 Asia Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Blastomycosis Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Blastomycosis Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Blastomycosis Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Blastomycosis Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Blastomycosis Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Blastomycosis Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Blastomycosis Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Blastomycosis Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Blastomycosis Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Blastomycosis Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Blastomycosis Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Blastomycosis Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Blastomycosis Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Blastomycosis Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Blastomycosis Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Blastomycosis Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Blastomycosis Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst